Published online May 7, 2015. doi: 10.3748/wjg.v21.i17.5119
Peer-review started: December 31, 2014
First decision: January 8, 2015
Revised: January 26, 2015
Accepted: March 18, 2015
Article in press: March 19, 2015
Published online: May 7, 2015
Processing time: 140 Days and 4.7 Hours
Currently, the major problem of all existing commercial capsule devices is the lack of control of movement. In the future, with an interface application, the clinician will be able to stop and direct the device into points of interest for detailed inspection/diagnosis, and therapy delivery. This editorial presents current commercially-available new designs, European projects and delivery capsule and gives an overview of the progress required and progress that will be achieved -according to the opinion of the authors- in the next 5 year leading to 2020.
Core tip: Currently, the major problem of all existing commercial capsule devices is the lack of control of movement. In the future, with an interface application, the clinician will be able to stop and direct the device into points of interest for detailed inspection/diagnosis, and therapy delivery. This editorial presents current commercially-available new designs, European projects and delivery capsule and gives an overview of the progress required and progress that will be achieved - according to the opinion of the authors- in the next 5 year leading to 2020.